Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide MMX in Mild or Moderate Active Ulcerative Colitis
NCT00679380Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 15
01
Overview
A Phase 3 trial of budesonide MMX in ulcerative colitis (UC), sponsored by Valeant Pharmaceuticals. Started Jun 2008; status: completed.
02
Drugs
budesonide MMX
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00679380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679380.